## **Core Concept**
The question involves the selection of an appropriate dosing regimen for an antiarrhythmic drug with a narrow therapeutic window, used in a critical condition such as severe ventricular arrhythmia following myocardial infarction. The drug's pharmacokinetics, including its half-life and therapeutic plasma concentration range, are crucial for determining the best dosing strategy.

## **Why the Correct Answer is Right**
The correct answer, , involves a loading dose followed by a maintenance dose. This approach is suitable for drugs with a narrow therapeutic window and a long half-life relative to the urgency of achieving therapeutic levels. A loading dose rapidly achieves the desired plasma concentration (minimum therapeutic level in this case) to quickly control the life-threatening arrhythmia. The maintenance dose then ensures that this therapeutic level is sustained. Given the drug's half-life of 6 hours and the need to maintain plasma concentrations above the minimum therapeutic level to prevent lethal arrhythmias, this regimen ensures efficacy while minimizing toxicity.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option does not involve a loading dose, which would result in a delay in achieving therapeutic plasma levels. Given the urgency of treating severe ventricular arrhythmia, this could be detrimental.
- **Option B:** This option suggests a constant rate of administration without an initial loading dose. It might not rapidly achieve the therapeutic level required to manage the arrhythmia effectively.
- **Option D:** Although this option involves administering the drug at a constant rate, similar to Option B, it lacks the specificity of achieving therapeutic levels quickly and maintaining them within a narrow therapeutic window.

## **Clinical Pearl / High-Yield Fact**
A key concept in pharmacology is that drugs with a narrow therapeutic index require careful dosing strategies, often necessitating a loading dose to quickly achieve therapeutic levels, followed by a maintenance dose to sustain those levels. This approach is critical in scenarios where the therapeutic goal is to rapidly achieve a specific plasma concentration to manage a life-threatening condition.

## **Correct Answer:** .